Reviva Pharmaceuticals Holdings, Inc.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| May 2018 | — | $-13.3K | $-13.3K |
| Aug 2018 | — | $-2.3K | $17.7K |
| Nov 2018 | — | $-79.1K | $263.2K |
| Feb 2019 | — | $-58.0K | $306.6K |
| May 2019 | — | $-71.1K | $338.4K |
| Aug 2019 | — | $-94.1K | $274.3K |
| Nov 2019 | — | $-166.0K | $136.8K |
| Feb 2020 | — | $-393.5K | $-131.7K |
| Mar 2020 | — | $-618.3K | $-749.0K |
| May 2020 | — | $-264.9K | $-155.8K |
| Jun 2020 | — | $-777.4K | $-851.4K |
| Aug 2020 | — | $-525.9K | $-516.0K |
| Sep 2020 | — | $-512.3K | $-659.1K |
| Nov 2020 | — | $-352.0K | $-348.2K |
| Dec 2020 | — | $-446.5K | — |
| Mar 2021 | — | $-1.9M | $-949.3K |
| Jun 2021 | — | $-1.8M | $-1.6M |
| Sep 2021 | — | $-2.5M | $-2.3M |
| Dec 2021 | — | $-4.0M | $-3.7M |
| Mar 2022 | — | $-7.5M | $-7.4M |
| Jun 2022 | — | $-5.5M | $-5.3M |
| Sep 2022 | — | $-5.5M | $-5.5M |
| Dec 2022 | — | $-9.8M | $-10.1M |
| Mar 2023 | — | $-7.0M | $-6.9M |
| Jun 2023 | — | $-11.3M | $-11.7M |
| Sep 2023 | — | $-11.6M | $-11.3M |
| Dec 2023 | — | $-9.6M | $-9.4M |
| Mar 2024 | — | $-7.9M | $-7.4M |
| Jun 2024 | — | $-8.1M | $-7.9M |
| Sep 2024 | — | $-8.5M | $-8.4M |
| Dec 2024 | — | $-6.3M | $-6.3M |
| Mar 2025 | — | $-6.5M | $-6.4M |
| Jun 2025 | — | $-6.1M | $-6.1M |
| Sep 2025 | — | $-4.0M | $-4.0M |
| Dec 2025 | — | $-3.6M | $-3.4M |
| Mar 2026 | — | $-3.3M | $-3.2M |
| Jun 2026 | — | $-2.6M | $-2.4M |